EPHX2 and acute myeloid leukemia: Moreover, Cox OS analysis suggested that EPHX2 was a protective factor in ACC, CESC, KIRC, LUAD, MESO, PAAD, and UVM, but a risk factor in acute myeloid leukemia (LAML) and LGG (Figure 4A).